glp 1 patents Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. π Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite New US$49 GLP-1 pill tests
Pay in 4 interest-free payments of $6.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18
























